{"id":"W1969110034","doi":"10.1016/j.jval.2011.02.962","title":"PCN108 CLINICAL EFFICACY AND ONCOLOGY REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE INTERIM JOINT ONCOLOGY DRUG REVIEW (IJODR)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); McMaster University","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Oncology; Reimbursement; Surrogate endpoint; Interim analysis; Clinical trial; Interim; Progression-free survival; Quality of life (healthcare); Cancer; Overall survival; Health care","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02434745,0.0009232936,0.002167618,0.005886672,0.002047155,0.007876942,0.003342392,0.008746471,0.00796571],"category_scores_gemma":[0.04920121,0.0009781631,0.002373405,0.007957308,0.001621715,0.001113218,0.001002994,0.006047851,0.002070001],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05279478,"about_ca_system_score_gemma":0.2528969,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.909219,"about_ca_topic_score_gemma":0.9613018,"domain_scores_codex":[0.9804441,0.003001044,0.001948635,0.0006366076,0.01160667,0.002362996],"domain_scores_gemma":[0.9345888,0.009988721,0.004154155,0.0007908046,0.04365491,0.00682254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003149636,0.00006931282,0.002293669,0.0007938055,0.0001418797,0.0000743901,0.00006168515,0.0007042009,0.0001389683,0.004899443,0.9418601,0.04864759],"study_design_scores_gemma":[0.0009923048,0.0001825764,0.03693726,0.004523587,0.000936763,0.0001417064,0.0001537902,0.001261673,0.000467954,0.001834408,0.9524206,0.0001474213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.01132149,0.2353598,0.001731621,0.5453559,0.0238235,0.002071175,0.04304791,0.0004433627,0.1368453],"genre_scores_gemma":[0.1703569,0.2459495,0.02071482,0.3145006,0.01387459,0.001860744,0.04156251,0.0006664599,0.1905138],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9472052,"threshold_uncertainty_score":0.3830547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7149667211583635,"score_gpt":0.5177786426742309,"score_spread":0.1971880784841326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}